CAR-macrophage therapy for HER2-overexpressing advanced solid tumors: a phase 1 trialKim A. Reiss, Yara Abdou, E. Claire Dees et al.|Nature Medicine|2025Cited by 189
Chimeric antigen receptor macrophages (CAR-M) sensitize HER2+ solid tumors to PD1 blockade in pre-clinical modelsStefano Pierini, Michael Klichinsky|Nature Communications|2025Cited by 80